2018 ASHP Midyear Clinical Meeting / Anaheim, California / Poster # 11-309
Objective: Evaluate bleeding and thrombotic risk of patients receiving triple antithrombotic therapy (TAT) versus dual antithrombotic therapy (DAT) and characterize prescribing patterns.
Lundy, Katharine PharmD; Meisberger, Elizabeth PharmD, BCPS; Howard, Kris PharmD, BCPS, AACC; and Sposito, Jennifer PharmD, "Evaluation of bleeding and thrombotic risk in patients receiving triple antithrombotic therapy" (2018). Pharmacy. 30.